New treatment for psoriasis

plaque psoriasis on hands
A new therapy has approved by the TGA for treatment of adults with moderate to severe plaque psoriasis Tremfya (guselkumab) is the first biologic approved in Australia that selectively blocks interleukin (IL)-23, a cytokine that plays a critical role in the pathogenesis of plaque psoriasis. Its approval by the TGA is based on clinical program

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next Navigating the stress of motherhood